Trial to Assess the Anti-inflammatory Effects of Roflumilast in Chronic Obstructive Pulmonary Disease
Clinical trial NCT01509677 · COMPLETED
Trial details
- NCT number
- NCT01509677
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-02-01
- Primary completion
- 2016-02-01
- Enrollment
- 158
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.